Utilization of human nuclear receptors as an early counter screen for off-target activity: a case study with a compendium of 615 known drugs

Toxicological Sciences : an Official Journal of the Society of Toxicology
Fan FanPaul Nioi

Abstract

Off-target effects of drugs on nuclear hormone receptors (NHRs) may result in adverse effects in multiple organs/physiological processes. Reliable assessments of the NHR activities for drug candidates are therefore crucial for drug development. However, the highly permissive structures of NHRs for vastly different ligands make it challenging to predict interactions by examining the chemical structures of the ligands. Here, we report a detailed investigation on the agonistic and antagonistic activities of 615 known drugs or drug candidates against a panel of 6 NHRs: androgen, progesterone, estrogen α/β, and thyroid hormone α/β receptors. Our study revealed that 4.7 and 12.4% compounds have agonistic and antagonistic activities, respectively, against this panel of NHRs. Nonetheless, potent, unintended NHR hits are relatively rare among the known drugs, indicating that such interactions are perhaps not tolerated during drug development. However, we uncovered examples of compounds that unintentionally agonize or antagonize NHRs. In addition, a number of compounds showed multi-NHR activities, suggesting that the cross-talk between multiple NHRs co-operate to elicit in vivo effects. These data highlight the merits of counter screenin...Continue Reading

References

Mar 1, 1975·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·V C Jordan, S Koerner
Jul 1, 1983·Contraception·J R SchreiberE E Baulieu
Dec 1, 1993·The Journal of Steroid Biochemistry and Molecular Biology·C A BerrevoetsE Mulder
Dec 15, 1995·Cell·D J MangelsdorfR M Evans
Feb 1, 1996·Nature Structural Biology·J M WurtzH Gronemeyer
Nov 21, 1996·Nature·S GimenoH Komen
May 7, 1998·The International Journal of Biochemistry & Cell Biology·S Tenbaum, A Baniahmad
Jul 13, 2000·Cellular and Molecular Life Sciences : CMLS·G I Owen, A Zelent
Jun 28, 2001·Physiological Reviews·A Aranda, A Pascual
Jul 7, 2001·Clinical Therapeutics·A M Pavlatos Pharmd
Jan 23, 2003·Journal of Cell Science·Marc Robinson-RechaviVincent Laudet
May 6, 2003·Toxicological Sciences : an Official Journal of the Society of Toxicology·George P DastonRobert J Kavlock
Jun 27, 2003·Journal of Medicinal Chemistry·Matthieu SchapiraMaxim Totrov
Nov 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Howard I Scher, Charles L Sawyers
Jan 4, 2006·American Journal of Obstetrics and Gynecology·Carl Djerassi
Jan 31, 2006·Current Opinion in Structural Biology·Andrew L HopkinsJohn P Overington
Feb 1, 1936·The Biochemical Journal·R Deanesly, A S Parkes
Jun 6, 2006·Toxicology and Applied Pharmacology·José-Manuel Molina-MolinaPatrick Balaguer
Aug 18, 2006·Molecular Aspects of Medicine·Paolo AscenziMaria Marino
Nov 28, 2006·Journal of Chemical Information and Modeling·Jordi MestresScott Boyer
Apr 27, 2007·Nature·Kathleen M GiacominiYusuke Nakamura
Apr 19, 1940·Science·W R Fish, R I Dorfman
Apr 2, 2009·Nature Reviews. Drug Discovery·John D Baxter, Paul Webb
May 13, 2009·Journal of Chemical Information and Modeling·Josef ScheiberJeremy L Jenkins
Jul 16, 2009·Current Opinion in Obstetrics & Gynecology·Irving M Spitz
Aug 1, 2009·Lancet·Denise J JamiesonUNKNOWN Novel Influenza A (H1N1) Pregnancy Working Group
Feb 13, 2010·Annual Review of Physiology·Pengxiang HuangFraydoon Rastinejad
Dec 15, 2010·The Journal of Biological Chemistry·David J ShapiroMilu T Cherian
Apr 16, 2011·American Journal of Obstetrics and Gynecology·Laura G GreerJeanne S Sheffield
May 6, 2011·Environmental Health Perspectives·Ruili HuangChristopher P Austin
Jul 21, 2011·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Takashi OtsukaKazuyuki Hirano
Jan 19, 2012·Cytotechnology·Hasan Basri Ila, Ahmet Ilhan
Apr 24, 2012·Toxicology and Applied Pharmacology·Angelo VedaniMartin Smieško
May 1, 2012·Toxicological Sciences : an Official Journal of the Society of Toxicology·Russell S ThomasRussell D Wolfinger
Jul 12, 2012·Systematic Biology·Daniel H Huson, Celine Scornavacca
Oct 12, 2012·Environmental Health Perspectives·Daniel M RotroffRichard S Judson
Apr 16, 2013·The Journal of Steroid Biochemistry and Molecular Biology·Martin HillAntonín Pařízek
Apr 16, 2013·American Journal of Obstetrics and Gynecology·Shigeru SaitoYasunori Yoshimura
May 15, 2013·Nucleic Acids Research·Hamish McWilliamRodrigo Lopez
Aug 3, 2013·The Journal of Steroid Biochemistry and Molecular Biology·Michael E BakerStephanie R Kattoula
Aug 21, 2013·Toxicological Sciences : an Official Journal of the Society of Toxicology·Ryan E MorganHisham K Hamadeh

❮ Previous
Next ❯

Citations

Apr 28, 2016·Breast Cancer Research and Treatment·A ThakkarTan A Ince
Mar 22, 2019·PLoS Pathogens·Chrissy M Leopold WagerLarry S Schlesinger
Feb 20, 2020·Military Medicine·Rajeev JaundooTravis J A Craddock
Apr 14, 2021·Alternatives to Laboratory Animals : ATLA·Varsha Bhat, Jhinuk Chatterjee
Jun 4, 2015·Journal of Chemical Information and Modeling·Nathalie LagardeMatthieu Montes

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.